Hormos Medical Corp. Has On May 24th Obtained New Dietary Ingredient (NDI) Clearance From The FDA To Market HMRlignan™ Containing Dietary Supplements In USA

Hormos Medical Corp. has on May 24th obtained new dietary ingredient (NDI) clearance from the FDA to market HMRlignan™ containing dietary supplements in USA. HMRlignan™ is a plant lignan isolated and purified from a natural source, the spruce tree. In humans HMRlignan™ serves as a precursor of enterolactone, a mammalian lignan. Low intake of lignan containing foodstuffs and/or low enterolactone serum levels are in epidemiological studies associated with increased risk of breast cancer and cardiovascular disease. HMRlignan™ is a highly purified lignan product which has been shown to effectively elevate the enterolactone levels at milligram doses already.
MORE ON THIS TOPIC